364 related articles for article (PubMed ID: 17404484)
1. [Inhibition of radiographic progression in rheumatoid arthritis by anti-rheumatic drugs (DMARDs)].
Suzuki Y; Wakabayashi T; Saito E; Suwa A
Clin Calcium; 2007 Apr; 17(4):546-52. PubMed ID: 17404484
[TBL] [Abstract][Full Text] [Related]
2. [Effect of disease modifying anti-rheumatic drugs on radiographic progression in rheumatoid arthritis].
Yukawa N; Mimori T
Clin Calcium; 2009 Mar; 19(3):395-403. PubMed ID: 19252250
[TBL] [Abstract][Full Text] [Related]
3. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.
Sharp JT; Strand V; Leung H; Hurley F; Loew-Friedrich I
Arthritis Rheum; 2000 Mar; 43(3):495-505. PubMed ID: 10728741
[TBL] [Abstract][Full Text] [Related]
4. Disease modification in rheumatoid arthritis with leflunomide.
Emery P
Scand J Rheumatol Suppl; 1999; 112():9-14. PubMed ID: 10668522
[TBL] [Abstract][Full Text] [Related]
5. Rational use of new and existing disease-modifying agents in rheumatoid arthritis.
Kremer JM
Ann Intern Med; 2001 Apr; 134(8):695-706. PubMed ID: 11304108
[TBL] [Abstract][Full Text] [Related]
6. [ Bone and cartilage destruction in RA and its intervention. Disease-modifying antirheumatic drugs].
Ichikawa N; Yamanaka H
Clin Calcium; 2012 Feb; 22(2):215-21. PubMed ID: 22298075
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study.
Finckh A; Dehler S; Gabay C;
Ann Rheum Dis; 2009 Jan; 68(1):33-9. PubMed ID: 18230627
[TBL] [Abstract][Full Text] [Related]
8. Effects of cyclosporin on joint damage in rheumatoid arthritis. The Italian Rheumatologists Study Group on Rheumatoid Arthritis.
Ferraccioli GF; Bambara LM; Ferraris M; Perpignano G; Cattaneo R; Porzio F; Accardo S; Mattara L; Zoppini A; Benucci M; Ostuni PA; Pasero G
Clin Exp Rheumatol; 1997; 15 Suppl 17():S83-9. PubMed ID: 9266138
[TBL] [Abstract][Full Text] [Related]
9. Radiographic progression in rheumatoid arthritis: results of 3 comparative trials.
van Riel PL; van der Heijde DM; Nuver-Zwart IH; van de Putte LB
J Rheumatol; 1995 Sep; 22(9):1797-9. PubMed ID: 8523366
[TBL] [Abstract][Full Text] [Related]
10. Psoriatic arthritis: treatment strategies using anti-inflammatory drugs and classical DMARDs.
Lubrano E; Scarpa R
Reumatismo; 2012 Jun; 64(2):107-12. PubMed ID: 22690387
[TBL] [Abstract][Full Text] [Related]
11. Approaches to the treatment of early rheumatoid arthritis with disease-modifying antirheumatic drugs.
Sizova L
Br J Clin Pharmacol; 2008 Aug; 66(2):173-8. PubMed ID: 18537958
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial.
Verschueren P; De Cock D; Corluy L; Joos R; Langenaken C; Taelman V; Raeman F; Ravelingien I; Vandevyvere K; Lenaerts J; Geens E; Geusens P; Vanhoof J; Durnez A; Remans J; Vander Cruyssen B; Van Essche E; Sileghem A; De Brabanter G; Joly J; Meyfroidt S; Van der Elst K; Westhovens R
Ann Rheum Dis; 2015 Jan; 74(1):27-34. PubMed ID: 25359382
[TBL] [Abstract][Full Text] [Related]
13. Effect of combination therapy on joint destruction in rheumatoid arthritis: a network meta-analysis of randomized controlled trials.
Graudal N; Hubeck-Graudal T; Tarp S; Christensen R; Jürgens G
PLoS One; 2014; 9(9):e106408. PubMed ID: 25244021
[TBL] [Abstract][Full Text] [Related]
14. [Disease modifying anti-rheumatic drugs (DMARDs): an overview].
Kawabata D; Mimori T
Nihon Rinsho; 2005 Jan; 63 Suppl 1():489-92. PubMed ID: 15799404
[No Abstract] [Full Text] [Related]
15. [2 years data of controlled trials with leflunomide vs. methotrexate and leflunomide vs. sulfasalazine].
Krüger K
Z Rheumatol; 2002 Jun; 61(3):308-10. PubMed ID: 12219638
[No Abstract] [Full Text] [Related]
16. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
Ciubotariu E; Gabay C; Finckh A;
J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
[TBL] [Abstract][Full Text] [Related]
17. Leflunomide for rheumatoid arthritis.
Drug Ther Bull; 2000 Jul; 38(7):52-4. PubMed ID: 11027115
[TBL] [Abstract][Full Text] [Related]
18. Medical therapy: where are we now?
Resman-Targoff BH
Am J Health Syst Pharm; 2006 Sep; 63(18 Suppl 4):S11-8. PubMed ID: 16960243
[TBL] [Abstract][Full Text] [Related]
19. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.
Lipsky PE; van der Heijde DM; St Clair EW; Furst DE; Breedveld FC; Kalden JR; Smolen JS; Weisman M; Emery P; Feldmann M; Harriman GR; Maini RN;
N Engl J Med; 2000 Nov; 343(22):1594-602. PubMed ID: 11096166
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of the clinical efficacy of four DMARDs (leflunomide, methotrexate, cyclosporine, and levamisole) in patients with rheumatoid arthritis.
Popovic M; Stefanovic D; Pejnovic N; Popovic R; Glisic B; Obradovic S; Dimitrijevic M
Transplant Proc; 1998 Dec; 30(8):4135-6. PubMed ID: 9865325
[No Abstract] [Full Text] [Related]
[Next] [New Search]
